Orchard Therapeutics, a clinical-stage biotechnology company, is opening a second facility for technical operations in the San Francisco Bay Area.   In combination with their existing site, they say the new facility quadruples Orchard’s laboratory footprint for the technical operations that support development, validation of processes, and controls for the manufacture of their gene therapy products.   Orchard’s pipeline includes clinical and pre-clinical stage autologous and ex-v...